Product
FARICIMAB (INYECTABLE)
Code 104075 · Official unit: AMPOLLA
$ 3.228.575
Reported spend
15Contracts
3Buying agencies
2Suppliers
15Items bought2024–2026
The Uruguayan state bought FARICIMAB (INYECTABLE) across 15 awards between 2024 and 2026. 3 agencies took part. The agency that bought most is Dirección Nacional de Sanidad de las Fuerzas Armadas. The supplier that sold most is ROCHE INTERNATIONAL LTD.
Purchases by year
Who buys it
Agencies that bought this product most often.
Who sells it
Suppliers that sold this product to the state most often.
Supplier concentration
How few suppliers account for this product's purchases: few suppliers signals a captive market.
Price dispersion
Unit-price range per currency and unit (p25 – p50 – p95). The wider the bar, the more what's paid varies.
Price reference
Price distribution per unit and currency over the last 36 months — the same baseline the price flags use.
| Unit | Typical (median) | Usual range | Comparables |
|---|---|---|---|
| UYU · vial | $ 37.909 | $ 31.591 – 44.227 | 12 |